Global research trends in prediabetes over the past decade: Bibliometric and visualized analysis

Guoyu Wang,Yafei Chen,Xinxin Liu,Siyi Ma,Min Jiang
DOI: https://doi.org/10.1097/md.0000000000036857
IF: 1.6
2024-01-20
Medicine
Abstract:Prediabetes is the stage of abnormal glucose metabolism between diabetes and normal blood glucose level and mainly includes 2 states, namely, impaired fasting glucose (IFG, fasting plasma glucose of 5.6–6.9 mmol/L) and impaired glucose tolerance (IGT, postload plasma glucose of 7.8 to 11.0 mmol/L based on 2 hours oral glucose tolerance test). The American Diabetes Association (ADA) has a lower threshold for IFG compared with the WHO but the same threshold for IGT. The ADA also includes hemoglobin A1c (HbA1C) levels of 5.7% to 6.4% as a new high-risk category for diabetes. In 2021, about 541 million of adults have IGT and about 319 million have IFG; by 2045, these numbers are projected to increase by 11.4% and 6.9%, respectively. [ 1 ] This condition imposes a great burden on the society and economy; thus, early diagnosis and control is necessary. In light of this, the ADA 2022 guidelines pointed to a trend toward younger diabetes, bringing the age of diabetes screening earlier from 45 to 35 years of age, with or without diabetes risk factors such as obesity, [ 2 ] and emphasizing the identification of people at risk for prediabetes. Therefore, a comprehensive quantitative analysis of the current situation, focus fields, and prospects for prediabetes is critical for developing effective prevention and control strategies.
medicine, general & internal
What problem does this paper attempt to address?